Insulin is not a scheduled drug. It does not appear on any of the five schedules of the federal Controlled Substances Act, and the Drug Enforcement Administration does not classify it as a controlled substance. You do not need a DEA-registered prescription to obtain it, and pharmacies are not required to track it the way they track opioids, stimulants, or benzodiazepines.
Why Insulin Is Not a Controlled Substance
The Controlled Substances Act assigns drugs to one of five schedules based on two main factors: whether the substance has accepted medical use and how likely it is to be abused or cause dependence. Schedule I includes drugs with no accepted medical use and high abuse potential, while Schedule V includes drugs with the lowest abuse potential. Insulin clearly has accepted medical use, but more importantly, it does not produce the kind of euphoria, psychological dependence, or addictive behavior that would place it on any schedule. People who take insulin do so because their bodies need it to survive, not because it creates a rewarding high.
That said, insulin can be dangerous. An overdose can cause severe hypoglycemia, seizures, coma, and death. It has been used in rare cases of self-harm and even homicide. Despite this potential for harm, the scheduling system is built around abuse and dependence potential rather than toxicity alone. Plenty of non-controlled medications, from blood thinners to heart drugs, can be lethal in the wrong dose without being scheduled.
How Insulin Is Regulated Instead
Insulin is regulated by the FDA as a prescription medication, but its regulatory path has changed significantly in recent years. For most of its history, insulin was approved and regulated as a drug under the Federal Food, Drug, and Cosmetic Act. In March 2020, insulin products were officially reclassified as biological products under the Public Health Service Act. The FDA defines a biological product, in part, as any protein with a specific, defined sequence greater than 40 amino acids in size. Insulin fits that definition.
This reclassification matters because it opened the door for biosimilar competition. Before 2020, generic-style alternatives to brand-name insulins faced a complicated approval pathway. Once insulin was treated as a biologic, manufacturers could submit applications for biosimilar or interchangeable versions of existing products. The FDA has since approved the first rapid-acting insulin biosimilar, a product called Merilog that is biosimilar to the widely used brand Novolog. These biosimilars are expected to increase competition and bring prices down over time.
Do You Need a Prescription?
In the United States, most modern insulin formulations (rapid-acting, long-acting, and premixed analogs) require a prescription. However, some older formulations of regular human insulin and NPH insulin are available over the counter at certain pharmacies without a prescription. This is a holdover from their original approval status and varies by state and retailer.
The fact that some insulin is available without a prescription further underscores that it is not a controlled substance. Controlled substances always require a prescription, and dispensing them involves additional tracking, reporting, and storage requirements that do not apply to insulin.
Insulin’s Status in Other Countries
Insulin is similarly unscheduled outside the United States. In the United Kingdom, it is not listed under the Misuse of Drugs Act 1971, the law that controls substances like opioids and amphetamines. It is regulated as a prescription-only medicine through separate pharmaceutical legislation but carries none of the restrictions applied to controlled drugs. Most other countries follow the same pattern: insulin is a regulated prescription medication, not a controlled or scheduled substance.
What This Means Practically
Because insulin is not a controlled substance, several things are simpler for people who use it. Prescriptions can typically be refilled without the same restrictions that apply to Schedule II drugs like certain ADHD medications or opioid painkillers, which often require a new written prescription each month. Traveling with insulin does not raise the legal complications that carrying a controlled substance might, though keeping it in its original labeled packaging is still a good idea for airport security and customs. Pharmacists can also transfer insulin prescriptions between pharmacies more easily than they can transfer controlled substance prescriptions, which face tighter transfer rules in many states.